Key result
Selective transarterial embolization controls refractory bleeding in 2 patients with advanced scalp angiosarcoma.
Why the study?
Severe tumor bleeding from ulcerated cutaneous scalp angiosarcoma is often difficult to control, particularly after chemoradiotherapy.
Does selective transarterial embolization control refractory bleeding in patients with advanced scalp angiosarcoma?
Case Report (n=2)
Does selective transarterial embolization control refractory bleeding in patients with advanced scalp angiosarcoma?
Selective transarterial embolization may provide rapid and effective control of refractory arterial bleeding in patients with advanced scalp angiosarcoma.
May control refractory bleeding in advanced scalp angiosarcoma; hypothesis-generating and requires prospective validation before clinical adoption.
Cutaneous angiosarcoma of the scalp is a highly aggressive vascular malignancy that predominantly affects elderly individuals and may cause severe tumor bleeding during disease progression. Hemorrhage from ulcerated tumors is often difficult to control, particularly in patients previously treated with chemoradiotherapy. We report two cases of advanced scalp angiosarcoma in which refractory tumor bleeding was successfully controlled by selective transarterial embolization. The first patient, a 75-year-old man with recurrent angiosarcoma of the frontal scalp region after multiple systemic therapies and radiotherapy, developed repeated arterial bleeding from ulcerated lesions requiring transfusion support. Angiography identified tumor-feeding branches of the superficial temporal artery and angular artery, and embolization achieved immediate hemostasis. A second embolization procedure was required for recurrent bleeding. The second patient, a 75-year-old woman, also developed persistent bleeding from a progressive scalp tumor despite chemoradiotherapy. Selective arterial embolization resulted in rapid and sustained bleeding control without major complications. These cases suggest that selective transarterial embolization may provide rapid control of refractory arterial tumor bleeding and reduce local treatment burden in selected patients with advanced scalp angiosarcoma.
No takes yet. Share an insight, caveat, or question.
Sakumoto et al. (2026) conducted a case report in Advanced scalp angiosarcoma with refractory bleeding (n=2). Selective transarterial embolization was evaluated on Bleeding control / hemostasis. Selective transarterial embolization achieved rapid and sustained control of refractory arterial tumor bleeding in 2 patients with advanced scalp angiosarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: